AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback